10/02/2024 3:58 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 6:07 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:08 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 3:43 PM | Gilead Sciences (Subject) Mercier Johanna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:45 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024 6:30 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:33 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/11/2024 6:38 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:41 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:20 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:23 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 2:23 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 1:23 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 4:17 PM | Gilead Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024 4:28 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 8:01 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/01/2024 7:06 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 7:31 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 7:35 PM | ASSEMBLY BIOSCIENCES, INC. (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/11/2024 6:12 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:15 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:18 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:20 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:23 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:25 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:57 PM | BARTON JACQUELINE K (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:16 PM | Gilead Sciences (Issuer) MANWANI HARISH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:23 PM | Gilead Sciences (Issuer) WELTERS ANTHONY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:26 PM | Gilead Sciences (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:30 PM | Gilead Sciences (Issuer) LOVE TED W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:08 PM | Bluestone Jeffrey (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 8:29 PM | GALAPAGOS NV (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
04/19/2024 3:31 PM | Gilead Sciences (Reporting) LEAP THERAPEUTICS, INC. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/19/2024 3:31 PM | Gilead Sciences (Filed by) LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
04/05/2024 3:31 PM | Gilead Sciences (Filed by) Xilio Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/03/2024 5:48 PM | Gilead Sciences (Reporting) Xilio Therapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 5:50 PM | Gilead Sciences (Reporting) Xilio Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:38 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 4:19 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 3:07 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/28/2024 3:07 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
Sell NVDA Now? (Ad) Guess who's selling NVDA next
The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). |
03/22/2024 8:21 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 6:50 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024 3:12 PM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:11 PM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024 3:19 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:11 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:14 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:59 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:03 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:34 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024 5:35 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:49 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:38 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 5:09 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024 4:48 PM | Gilead Sciences (Reporting) Kyverna Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 7:37 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:39 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-C | |
02/09/2024 5:21 PM | Capital World Investors (Filed by) Gilead Sciences (Subject)
| Form SC 13G/A | |
02/07/2024 4:35 PM | Gilead Sciences (Reporting) Kyverna Therapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/06/2024 5:01 PM | Gilead Sciences (Issuer) LOVE TED W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:20 PM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 1:42 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:34 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:19 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:11 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 12:40 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:58 PM | Arcus Biosciences, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
01/31/2024 4:00 PM | Arcus Biosciences, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Gilead Sciences (Subject)
| Form SC 13G/A | |
01/17/2024 5:01 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:32 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:35 PM | Gilead Sciences (Subject) Mercier Johanna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023 3:36 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:06 PM | Arcellx, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13G/A | |
12/28/2023 4:09 PM | Arcellx, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2023 3:07 PM | Gilead Sciences (Reporting) HOOKIPA Pharma Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/11/2023 6:00 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:04 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:08 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:10 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:15 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 5:21 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 4:18 PM | Gilead Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023 4:56 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2023 6:15 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer) Gilead Sciences (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/25/2023 4:18 PM | ASSEMBLY BIOSCIENCES, INC. (Subject) Gilead Sciences (Filed by)
| Form SC 13D | |
10/19/2023 2:33 PM | Gilead Sciences (Filed by) Ikena Oncology, Inc. (Subject)
| Form SC 13G | |
10/18/2023 3:31 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:18 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |